Literature DB >> 30641684

Evaluation of serum adiponectin levels in diabetic nephropathy.

Alshaimaa Rezk L R Alnaggar1, Mohamed Sayed2, Kareem Essam El-Deena2, Mohamed Gomaa2, Yousra Hamed3.   

Abstract

INTRODUCTION: Diabetic nephropathy is one of the major microvascular complications of diabetes mellitus. Adiponectin is an adipose tissue-derived cytokine that was identified in a human adipose tissue cDNA library. Serum adiponectin levels are found to be reduced in various pathological states including obesity, diabetes mellitus, ischaemic heart disease and arteriosclerosis obliterans and elevated in end stage renal diseases.
OBJECTIVE: to assess the level of plasma adiponectin as an early predictor of microvascular complications in patients with type 2 diabetes mellitus.
METHODS: 44 patients with type 2 diabetes recruited from outpatient diabetes clinic in Kasr Alainy hospital. All patients were subjected to full laboratory work-up including: Fasting blood glucose and Post prandial blood glucose, Glycated haemoglobin A1C, Serum creatinine, Serum total cholesterol, Triglycerides, Low density lipoprotein, High density lipoprotein, C-reactive protein titre, serum adiponectin and Urinary albumin/creatinine (UAC) ratio.
RESULTS: The present study demonstrated that serum adiponectin concentrations had significant positive correlation with UAC ratio (r = 0.534, p = 0.0001). Adiponectin levels showed significant positive correlation in patients with diabetes and hypertension with microalbumiuria (p = .001) or normoalbumiuria (p = 0.004).
CONCLUSION: Serum adiponectin level can be a good predictor of diabetic nephropathy in patients with type 2 diabetes mellitus.
Copyright © 2018 Diabetes India. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Diabetic nephropathy; Microalbuminuria; Serum adiponectin; Type II diabetes

Mesh:

Substances:

Year:  2018        PMID: 30641684     DOI: 10.1016/j.dsx.2018.04.035

Source DB:  PubMed          Journal:  Diabetes Metab Syndr        ISSN: 1871-4021


  6 in total

Review 1.  ADIPOQ rs2241766 Gene Polymorphism and Predisposition to Diabetic Kidney Disease.

Authors:  Qiuxia Han; Wenjia Geng; Dong Zhang; Guangyan Cai; Hanyu Zhu
Journal:  J Diabetes Res       Date:  2020-06-28       Impact factor: 4.011

2.  Study the Association of Tumor Necrosis Factor Promoter Polymorphism with Type 2 Diabetic Nephropathy.

Authors:  Mahmoud Emara; Rawhia El-Edel; Waleed M Fathy; Noran T Aboelkhair; Mona M Watany; Dalia H Abou-Elela
Journal:  Mediators Inflamm       Date:  2020-07-01       Impact factor: 4.711

Review 3.  Adipokines and Obesity. Potential Link to Metabolic Disorders and Chronic Complications.

Authors:  Katarzyna Zorena; Olga Jachimowicz-Duda; Daniel Ślęzak; Marlena Robakowska; Małgorzata Mrugacz
Journal:  Int J Mol Sci       Date:  2020-05-18       Impact factor: 5.923

Review 4.  The Pathogenesis of End-Stage Renal Disease from the Standpoint of the Theory of General Pathological Processes of Inflammation.

Authors:  Evgenii Gusev; Liliya Solomatina; Yulia Zhuravleva; Alexey Sarapultsev
Journal:  Int J Mol Sci       Date:  2021-10-23       Impact factor: 5.923

5.  Serum isthmin-1 levels are positively and independently correlated with albuminuria in patients with type 2 diabetes mellitus.

Authors:  Chuan Wang; Mingyue Xu; Ruiying Feng; Lei Zhang; Xiaofei Yin; Ruoqi Feng; Kai Liang; Jinbo Liu
Journal:  BMJ Open Diabetes Res Care       Date:  2022-09

Review 6.  Adiponectin in renal fibrosis.

Authors:  Huan Jing; Simin Tang; Sen Lin; Meijuan Liao; Hongtao Chen; Youling Fan; Jun Zhou
Journal:  Aging (Albany NY)       Date:  2020-02-17       Impact factor: 5.682

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.